GLP-1 Medication Use for Type 2 Diabetes Has Soared

This JAMA Data Brief discusses new data from the Medical Expenditure Panel Survey, or MEPS, Household Component, a household survey sponsored by the Agency for Healthcare Research and Quality.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2024-08-30
DOI
https://doi.org/10.1001/jama.2024.18219
Citations
32
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
11.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLP-1 Medication Use for Type 2 Diabetes Has Soared

Thomas A. Hegland, Zhengyi Fang, K. E. Bucher
32 citations
JAMA
Diabetes Treatment and Management
11.45
article

GLP-1 Medication Use for Type 2 Diabetes Has Soared

Thomas A. Hegland, Zhengyi Fang, K. E. Bucher
article en
32 citations

Abstract

This JAMA Data Brief discusses new data from the Medical Expenditure Panel Survey, or MEPS, Household Component, a household survey sponsored by the Agency for Healthcare Research and Quality.

JAMAVol. 332(12)
Agency for Healthcare Research and Quality (US)
Openalex Percentile: Top 1%
Diabetes Treatment and Management
11.45
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1 Medication Use for Type 2 Diabetes Has Soared — Thomas A. Hegland, Zhengyi Fang, et al. · JAMA (2024) | TGRS Research Map | TGRS